BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.870
-0.040 (-1.02%)
At close: Oct 12, 2026, 4:00 PM EDT
3.820
-0.050 (-1.29%)
Pre-market: Oct 13, 2026, 6:45 AM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $34.21 million as of October 12, 2026. Its market cap has increased by 307.21% in one year.
Market Cap
34.21M
Enterprise Value
11.83M
1-Year Change
307.21%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $34.21M, an increase of 31.56%. That is a compound annual growth rate of 4.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 34.21M | 155.27% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 38.86M |
| Metagenomi Therapeutics | 38.34M |
| Lite Strategy | 37.86M |
| Impact BioMedical | 37.51M |
| Filana Therapeutics | 37.25M |
| Aligos Therapeutics | 34.47M |
| Actinium Pharmaceuticals | 33.64M |
| GridAI Technologies | 33.56M |